Suite 410-103 East Holly Street
Bellingham, WA 98225
Telephone: (360) 306 1133
Fax: (360) 230-7304
› Back › Home › Contact
News

Wall Street News Alert: Hot Stock to Watch: Caleco Pharma Corp. -- February 24, 2010 (Marketwire via Yahoo! Finance)
WESTON, FL--(Marketwire - 02/24/10) - Wall Street News Alert's "stocks to watch" this morning are: Caleco Pharma Corp. (OTC.BB: CAEH - News ), Cephalon, Inc. (NASDAQ: CEPH - News ), Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA - News ) and Amgen, Inc. (NASDAQ: AMGN - News ). Caleco Pharma Corp. (OTC.BB: CAEH - News ), a biopharmaceutical and consumer health products company, issued a press ...
Wed, 24 Feb 2010

Wall Street News Alert: Trade Alert: Caleco Pharma Corp. -- February 24, 2010 (Marketwire via Yahoo! Finance)
CAEH ), a biopharmaceutical and consumer health products company, issued a press release yesterday providing insight into the development strategy for its lead, patent protected product line that targ...
Wed, 24 Feb 2010

Hot Stock to Watch: Caleco Pharma Corp. -- February 24, 2010 (MalaysiaNews.net)
BELLINGHAM, WASHINGTON--(Marketwire - 02/23/10) - Caleco Pharma Corp. (the "Company" or "Caleco") (OTC.BB: CAEH - News )(Frankfurt: T3R - News )(WKN: A0N9Y0) ( www.calecopharmacorp.com ), a biopharmaceutical and consumer health products company that identifies and develops biotech products, today provides insight into the development strategy for its lead, patent ...
Wed, 24 Feb 2010

Market Demand for Caleco's Liver Health Formulation (Marketwire via Yahoo! Finance)
BELLINGHAM, WASHINGTON-- - Caleco Pharma Corp. , a biopharmaceutical and consumer health products company that identifies and develops biotech products, today provides insight into the development strategy for its lead, patent protected product line that targets a segment of the market that includes millions of people suffering from various liver maladies, especially the Hepatitis C Virus .
Tue, 23 Feb 2010

Market Demand for Caleco's Liver Health Formulation (CCNMatthews via Yahoo! Finance)
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.
Tue, 23 Feb 2010

Wall Street News Alert: Hot Stock to Watch: Caleco Pharma Corp. -- February 24, 2010 (Marketwire)
BELLINGHAM, WASHINGTON-- - Caleco Pharma Corp. , a biopharmaceutical and consumer health products company focused on developing a broad pipeline of products derived from natural sources, today reports the signing of a Laboratory Facilities and Service Agreement with Natac Biotech S.L., a Spanish biotechnology corporation engaged in the research and development of health related products.
Wed, 24 Feb 2010

Laboratory Facilities and Service Agreement Signed by Caleco Pharma Corp. (CCNMatthews via Yahoo! Finance)
BELLINGHAM, WASHINGTON--(Marketwire - 02/18/10) - Caleco Pharma Corp. (the "Company" or "Caleco") (OTC.BB: CAEH - News )(Frankfurt: T3R - News )(WKN: A0N9Y0) ( www.calecopharmacorp.com ), a biopharmaceutical and consumer health products company focused on developing a broad pipeline of products derived from natural sources, today reports the signing of a Laboratory ...
Thu, 18 Feb 2010

Laboratory Facilities and Service Agreement Signed by Caleco Pharma Corp. (Marketwire via Yahoo! Finance)
Company reports on early success of its lead product to inhibit the growth of Hepatitis C virus
Thu, 18 Feb 2010


| Welcome | Caleco Pharma | Health Products | Drug Development | Health Products | Drug Development | Scientific | News | Investors | Contacts |
Caleco Pharma Corp.  All Content Copyright 2009 All Rights Reserved. Optimized for | The website was created in 1.32613 seconds.